Stereotaxis (STXS) Preferred Stock Liabilities (2010 - 2026)
Stereotaxis' (STXS) quarterly Preferred Stock Liabilities came in at $5.2 million in Q1 2026, down 1.06% year-on-year from $5.3 million in Q1 2025, and little changed on a QoQ basis from $5.2 million in Q4 2025.
Stereotaxis (STXS) Preferred Stock Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 12 years of Preferred Stock Liabilities data on file, last reported at $5.2 million in Q1 2026.
- On a quarterly basis, Preferred Stock Liabilities fell 1.06% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 1.06% decrease from a year earlier, with the FY2025 full-year figure at $5.2 million, down 2.09% from the prior year.
- Preferred Stock Liabilities for Q1 2026 stood at $5.2 million, roughly flat from $5.2 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for STXS reached as high as $5.6 million in Q1 2022 and fell as low as $5.2 million in Q4 2025.
- Historically, Preferred Stock Liabilities has averaged $5.4 million across 5 years, with a median of $5.5 million in 2024.
- Across the five-year window, Preferred Stock Liabilities advanced 0.1% in 2022 and decreased 4.03% in 2024, its largest moves.
- Year by year, Preferred Stock Liabilities stood at $5.6 million in 2022, then slipped by 0.11% to $5.6 million in 2023, then declined by 4.03% to $5.4 million in 2024, then dropped by 2.09% to $5.2 million in 2025, then changed by 0.0% to $5.2 million in 2026.
- Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $5.2 million in Q1 2026, $5.2 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | 5.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 5.24 Mn |
| Sep 30, 2025 | 5.27 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 5.41 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | 5.58 Mn |
| Mar 31, 2023 | 5.58 Mn |
| Dec 31, 2022 | 5.58 Mn |
| Sep 30, 2022 | 5.58 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 5.58 Mn |
| Dec 31, 2021 | 5.58 Mn |
| Sep 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | 5.58 Mn |